Frontlight ResearchEarly access
Taking people in HungaryPhase 4
Testing a heart-rate medicine during a heart scan in people with atrial fibrillation
Tests a beta-blocker medicine before a heart CT scan in adults with atrial fibrillation.
Key facts
- Who runs it
- Semmelweis University
- Where
- Budapest XII, HungarySee the site
- Trial code
- Registry title
- The Role of Beta-Blockade During Cardiac CT in Patients with Atrial Fibrillation
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 136 people, planned
- Started
- 20 Jan 2026
- Planned end
- 1 Oct 2026
- Type of study
- Interventional
- Record updated
- 22 October 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with atrial fibrillation or coronary artery disease. It studies beta-blockers given during a cardiac CT scan.
- Age
- 18 years or older
- Sex
- All sexes can join
Where in Hungary
- Semmelweis UniversityBudapest XII, HungaryTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Testing a heart-rate medicine during a heart scan in people with atrial fibrillationGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 22 October 2025